About Us
Home
News & Events
Useful Links
Careers
Contact Us
Site Map
cobra:bio
Bio Services
Fill/Finish
Quality
Technologies
DNA
Cobra Biologics is a leading international cGMP manufacturer of plasmid DNA for preclinical and clinical supply. Our success comes from the experience and expertise gained as a solution provider.
Molecular Biology
Cloning (any gene from any source)
Proprietary technology:
Antibiotic free maintenance technology (ORT
®
)
Qualified strains (examples):
DH1
DH1-ORT
DH5α
Plasmid stability testing
Vector development: plasmid and strain construction
Sequencing
Process Development & Scale Up
Fermentation & media development
Evaluation of productivity and optimisation of harvest point
Lysis optimisation (primary recovery)
Non-animal derived components
Production for pre-clinical efficacy testing and pivotal preclinical safety testing
Formulation
Analytical Development & Qualification
Assay transfer
Product characterization
QC release testing
QC testing of Drug Substance & Drug Product
Stability studies: Drug Substance and Drug Product
To ICH guidelines
Forced degradation studies
Cleaning validation
Raw material testing
Shipping studies
cGMP Manufacturing
Master Cell Bank & Working Cell Bank production
Pre-clinical & clinical supply
Fill / Finish
Aceptic production
Syringes and vials
Freeze-drying / lyophilisation
Clinical scale supply
Primary / Secondary Labelling
Primary labelling (or re-labelling) of drug product vials for human clinical centres
Secondary packaging and labelling of vials for dispatch to clinical centres
Tertiary and transport labelling & packaging as required
Guidance on regulatory requirements and details of primary and secondary labels
Fully traceable clinical labelling to batch records, under QA observation with QP review and issue of cGMP Certificate of Compliance
Phase I and Phase II labelling supporting clinical trials worldwide
Regulatory documents review as required to support release to clinic
Quality Assurance & Regulatory Support
Two Qualified Persons (QP)
Fully compliant with European Clinical trials Directive 2001/20/EC and FDA standards
Authorised by UK MHRA for the cGMP production of Investigational Medicinal Products (IMPs)
Support customers with their CMC filings
Representation at MHRA and FDA meetings
QP release
Shipment to clinical trial sites
Project Management
Dedicated Project Manager
Cross-functional project teams
Detailed timeline planning
Milestone tracking
Program managed by single point of contact
Regular process updates & risk management
DNA Services (370K) PDF
First client product Cobra manufactured was DNA in 1998
News Alert
View privacy policy